Meta-analysis of trials comparing β-blockers, calcium antagonists, and nitrates for stable angina

JAMA

Volumn 281, Issue 20, 1999, Pages 1927-1936

  Heidenreich, Paul A ^a,b,c   McDonald, Kathryn M ^b,c   Hastie, Trevor ^b,d   Fadel, Bahaa ^c   Hagan, Vivian ^b   Lee, Byron K ^c   Hlatky, Mark A ^b,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD LAW SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIANGINA PECTORIS AGENT; ATENOLOL; BEPRIDIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BOPINDOLOL; CALCIUM ANTAGONIST; CARVEDILOL; DILTIAZEM; EPANOLOL; FELODIPINE; GLYCERYL TRINITRATE; LABETALOL; METOPROLOL; NADOLOL; NICARDIPINE; NIFEDIPINE; NITRIC ACID DERIVATIVE; PENBUTOLOL; PINDOLOL; PROPRANOLOL; VERAPAMIL;

ANGINA PECTORIS; CLINICAL TRIAL; DRUG RESEARCH; DRUG SCREENING; DRUG WITHDRAWAL; EXERCISE; HEART DEATH; HEART INFARCTION; HUMAN; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW;

EID: 0033606289     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.20.1927     Document Type: Review

References (118)

1. 1998 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 1998.
2. Gersh B, Braunwald E, Rutherford J. Chronic coronary artery disease. In: Braunwald E, ed. Heart Disease. 5th ed. Philadelphia, Pa: WB Saunders Co; 1997: 307-335.
3. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction. Prog Cardiovasc Dis. 1985;27:335-371.
4. North of England Stable Angina Guideline Development Group. North of England Evidence Based Guidelines Development Project. BMJ. 1996;312:827-832.
5. Management of stable angina pectoris: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 1997;18:394-413.
6. Chan PK, Heo JY, Garibian G, et al. The role of nitrates, beta blockers, and calcium antagonists in stable angina pectoris. Am Heart J. 1988;116:838-848.
7. Fox KM, Jespersen CM, Ferrari R, Rehnqvist N. How European cardiologists perceive the role of calcium antagonists in the treatment of stable angina. Eur Heart J. 1997;18(suppl A):A113-A116.
8. Hoekenga D, Abrams J. Rational medical therapy for stable angina pectoris. Am J Med. 1984:76:309-314.
9. Thadani U. Management of patients with chronic stable angina at low risk for serious cardiac events. Am J Cardiol. 1997;79:24-30.
10. Roberts R. Stable angina as a manifestation of ischemic heart disease. Circulation. 1985;72:V145-V154.
11. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
12. Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
13. Furberg CD, Psaty BM. Corrections to the nifedipine meta-analysis. Circulation. 1996;93:1475-1476.
14. Califf RM, Kramer JM. What have we learned from the calcium channel blocker controversy? Circulation. 1998;97:1529-1531.
15. Shadish W, Haddock C. Combining estimates of effect size. In: Cooper H, Hedges L, eds. The Handbook of Research Synthesis. 5th ed. New York, NY: Russel Sage Foundation; 1994:307-335.
16. Petitti D. Statistical Methods in Meta-Analysis: Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis. New York, NY: Oxford University Press; 1994:90-114.
17. DerSimonian R. Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
18. Hedges L. Fixed effects models. In: Cooper H, Hedges L, eds. The Handbook of Research Synthesis. 5th ed. New York, NY: Russel Sage Foundation; 1994:307-335.
19. Wallace WA, Wellington KL, Chess MA, Liang CS. Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris. Am J Cardiol. 1994;73:23-28.
20. von Arnim T. Medical treatment to reduce total ischemic burden. J Am Coll Cardiol. 1995;25:231-238.
21. Savonitto S, Ardissiono D, Egstrup K, et al. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. J Am Coll Cardiol. 1996;27:311-316.
22. Johnson SM, Mauritson DR, Corbett JR, et al. Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris. Am J Med. 1981;71:443-451.
23. Di Somma S, de Divitiis M, Bertocchi F, et al. Treatment of hypertension associated with stable angina pectoris. Cardiologia. 1996;41:635-643.
24. Bowles MJ, Bala Subramanlan V, Davies AB, Raftery EB. Double-blind randomized crossover trial of verapamil and propranolol in chronic stable angina. Am Heart J. 1983;106:1297-1306.
25. Ardissino D, Savonitto S, Egstrup K, et al. Selection of medical treatment in stable angina pectoris. J Am Coll Cardiol. 1995;25:1516-1521.
26. van der Does R, Eberhardt R, Derr I, Ehmer B. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina. J Cardiovasc Pharmacol. 1992;19(suppl 1):S122-S127.
27. Lynch P, Dargie H, Krikler S, Krikler D. Objective assessment of antianginal treatment. BMJ. 1980;281: 184-187.
28. Rae AP, Beattie JM, Lawrie TD, Hutton I. Comparative clinical efficacy of bepridil, propranolol and placebo in patients with chronic stable angina. Br J Clin Pharmacol. 1985;19:343-352.
29. Kawanishi DT, Reid CL, Morrison EC, Rahimtoola SH. Response of angina and ischemia to long-term treatment in patients with chronic stable angina. J Am Coll Cardiol. 1992;19:409-417.
30. Pflugfelder PW, Humen DP, O'Brien PA, et al. Comparison of bepridil with nadolol for angina pectoris. Am J Cardiol. 1987;59:1283-1288.
31. McGill D, McKenzie W, McCredie M. Comparison of nicardipine and propranolol for chronic stable angina pectoris. Am J Cardiol. 1986;57:39-43.
32. Humen DP, Kostuk WJ. Clinical response and effects on left ventricular function of isosorbide dinitrate added to propranolol or diltiazem monotherapy in patients with chronic stable angina. Can J Cardiol. 1991;7:74-80.
33. Frishman WH, Klein NA, Klein P, et al. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. Am J Cardiol. 1982;50:1164-1172.
34. Nadazdin A, Davies GJ. Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina. Am Heart J. 1994; 127:312-317.
35. De Divitiis O, Liguori V, Di Somma S, et al. Biso-prolol in the treatment of angina pectoris. Eur Heart J. 1987;8(suppl M):43-54.
36. Crake T, Mulcahy D, Wright C, Fox K. Labetalol in the treatment of stable exertional angina pectoris. fur Heart J. 1988;9:1200-1205.
37. Higginbotham MB, Morris KG, Coleman RE, Cobb FR. Chronic stable angina monotherapy. Am J Med. 1989;86:1-5.
38. Southall E, Nutt NR, Thomas RD. Chronic stable angina. J Int Med Res. 1982;10:361-366.
39. Wheatley D. A comparison of diltiazem and atenolol in angina. Postgrad Med J. 1985;61:785-789.
40. Hauf-Zachariou U, Blackwood RA, Gunawardena KA, et al. Carvedilol versus verapamil in chronic stable angina. Eur J Clin Pharmacol. 1997;52:95-100.
41. Steffensen R, Grande P, Pedersen F, Haunso S. Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia. Int J Cardiol. 1993; 40:143-153.
42. Bjerle P, Olofsson B, Glimvik O. Nicardipine and propranolol in angina pectoris. Br J Clin Pharmacol. 1986;22(suppl):339S-343S.
43. Findlay IN, Dargie HJ. The effects of nifedipine, atenolol and that combination on left ventricular function. Postgrad Med J. 1983;59(suppl 2):70-73.
44. Findlay IN, MacLeod K, Ford M, Gillen G, Elliott AT, Dargie HJ. Treatment of angina pectoris with nifedipine and atenolol. Br Heart J. 1986;55:240-245.
45. Findlay IN, MacLeod K, Gillen G, et al. A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris. Br Heart J. 1987;57:336-343.
46. Livesley B, Catley PF, Campbell RC, Oram S. Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris. BMJ. 1973;1:375-378.
47. Frishman WH. Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris. Am J Cardiol. 1992;69: 50D-55D.
48. van Dijk RB, Lie KI, Crijns HJ. Diltiazem in comparison with metoprolol in stable angina pectoris. Eur Heart J. 1988;9:1194-1199.
49. Kenny J, Kiff P, Holmes J, Jewitt DE. Beneficial effects of diltiazem and propranolol, alone and in combination, in patients with stable angina pectoris. Br Heart J. 1985;53:43-46.
50. Arnman K, Ryden L. Comparison of metoprolol and verapamil in the treatment of angina pectoris. Am J Cardiol. 1982;49:821-827.
51. Ahuja RC, Sinha N, Kumar RR, Saran RK. Effect of metoprolol and diltiazem on the total ischaemic burden in patients with chronic stable angina. Int J Cardiol. 1993;41:191-199.
52. Parameshwar J, Keegan J, Mulcahy D, et al. Atenolol or nicardipine alone is as efficacious in stable angina as their combination. Int J Cardiol. 1993;40: 135-141.
53. Sadick NN, Tan AT, Fletcher PJ, Morris J, Kelly DT. A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina. Circulation. 1982;66:574-579.
54. Hung J, Lamb IH, Connolly SJ, Jutzy KR, Goris ML, Schroeder JS. The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina. Circulation. 1983;68:560-567.
55. Egstrup K, Andersen PE Jr. Transient myocardial ischemia during nifedipine therapy in stable angina pectoris, and its relation to coronary collateral flow and comparison with metoprolol. Am J Cardiol. 1993;71: 177-183.
56. Lai C, Onnis E, Orani E, et al. Felodipine improves the anti-ischaemic effect of metoprolol in stable effort-induced angina. Drug Invest. 1992;4:30-33.
57. Bowles MJ, Subramanian VB, Davies AB, Raftery EB. Comparison of antianginal actions of verapamil and propranolol. BMJ. 1981;282:1754.
58. Parker JO, Farrell B. Comparative antianginal effects of bepridil and propranolol in angina pectoris. Am J Cardiol. 1986;58:449-452.
59. Hopkinson ND, Hui KP, Smith MP, Hollinrake K. A comparison of sustained release verapamil versus atenolol for 24 h protection from exercise-induced angina pectoris. Eur Heart J. 1991;12:1273-1277.
60. Romano M, Di Maro T, Carella G, et al. Atenolol and/or nifedipine in effort angina. Int J Clin Pharmacol Ther Toxicol. 1988;26:468-470.
61. Catipovic-Veselica K, Skrinjaric-Cincar S, Catipovic B. Efficacy of diltiazem and penbutolol in myocardial ischemia of patients with stable angina pectoris. Croat Med J. 1993;34:319-324.
62. Johnston DL, Manyari DE, Kostuk WJ. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris. CMAJ. 1984;130:1449-1455.
63. Cocco G, Strozzi C, Chu D, Amrein R, Castagnoli E. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. Eur J Cardiol. 1979;10:59-69.
64. Rousseau MF, Hanet C, Pardonge-Lavenne E, et al. Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine. Circulation. 1986;73:1270-1280.
65. Romano M, di Maro T, Cotecchia MR, et al. Long-term management of exercise-induced myocardial ischemia. Int J Clin Pharmacol Ther Toxicol. 1986; 24:551-554.
66. Logan R, Ikram H, Webster M, Guppy W. Comparative efficacy of nicardipine hydrochloride and atenolol in the treatment of chronic stable angina. Br J Clin Pharmacol. 1986;22(suppl):345S-350S.
67. Rehnqvist N, Hjemdahl P, Billing E, et al. Effects of metoprolol vs verapamil in patients with stable angina pectoris. Eur Heart J. 1996;17:76-81.
68. Lessem J. Combined therapy with Ca-antagonists and beta-adrenergic receptor blocking agents in chronic stable angina. Acta Med Scand Suppl. 1984; 681:83-90.
69. Johnston DL, Gebhardt VA, Donald A, Kostuk WJ. Comparative effects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina. Circulation. 1983;68:1280-1289.
70. de Vries RJ, van den Heuvel AF, Lok DJ, et al. Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. Int J Cardiol. 1996; 57:143-150.
71. Dargie HJ, Ford I, Fox KM. Total Ischaemic Burden European Trial (TIBET). Eur Heart J. 1996;17:104-112.
72. Vliegen HW, van der Wall EE, Kragten JA, et al. Comparison of diltiazem standard formulation and diltiazem controlled release in patients with stable angina pectoris. J Cardiovasc Pharmacol. 1993;21:552-559.
73. Shapiro W, Narahara KA, Kostis JB, et al. Comparison of atenolol and nifedipine in chronic stable angina pectoris. Am J Cardiol. 1989;64:186-190.
74. Ardissino D, Savonitto S, Egstrup K, et al. Transient myocardial ischemia during daily life n rest and exertional angina pectoris and comparison of effectiveness of metoprolol versus nifedipine. Am J Cardiol. 1991;67:946-952.
75. Blake P, Berry SC, Readman A, Ratcliffe M, Godley M. A comparison of epanolol and nifedipine in stable angina patients. Cardiology. 1991;79:249-255.
76. Miller WE, Vittitoe J, O'Rourke RA, Crawford MH. Nadolol versus diltiazem and combination for preventing exercise-induced ischemia in severe angina pectoris. Am J Cardiol. 1988;62:372-376.
77. Hill JA, Gonzalez JI, Kolb R, Pepine CJ. Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia. Am J Cardiol. 1991;67:671-675.
78. Egstrup K. Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina. Am Heart J. 1988;116:971-978.
79. Destors JM, Boissel JP, Philippon AM, Schbath J. Controlled clinical trial of bepridil, propranolol and placebo in the treatment of exercise induced angina pectoris. Fundam Clin Pharmacol. 1989;3:597-611.
80. Meyer EC, Makov UE, Palant A. Monctherapy of stable angina pectoris with bopindolol in comparison with diltiazem. Cardiology. 1991;78:179-184.
81. Riley M, Elborn JS, Khan MM, Stanford CF, et al. Comparative effects of epanolol and diltiazem on exercise performance and respiratory gas exchange in angina pectoris. Eur Heart J. 1992;13:1116-1122.
82. Singh S. Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. Clin Cardiol. 1993;16:54-58.
83. O'Hara MJ, Khurmi NS, Bowles MJ, et al. Comparison of diltiazem at two dose levels with propranolol for treatment of stable angina pectoris. Am J Cardiol. 1984;54:477-481.
84. Brouwer J, Viersma JW, van Veldhuisen DJ, et al. Usefulness of heart rate variability in predicting drug efficacy (metoprolol vs diltiazem) in patients with stable angina pectoris. Am J Cardiol. 1995;76:759-763.
85. Khurmi NS, O'Hara MJ, Bowles MJ, Raftery EB. Effect of diltiazem and propranolol on myocardial ischaemia during unrestricted daily life in patients with effort-induced chronic stable angina pectoris. Eur J Clin Pharmacol. 1987;32:443-447.
86. Sigurd B, Hansen JF. Verapamil or propranolol in the treatment of stable angina pectoris of effort. Acta Med Scand Suppl. 1984;681:75-81.
87. Kenmure AC, Scruton JH. A double-blind controlled trial of the anti-anginal efficacy of nifedipine compared with propranolol. Br J Clin Pract. 1979;33:49-51.
88. Lai C, Onnis E, Pirisi R, et al. Anti-ischaemic and anti-anginal activity of atenolol, nifedipine and their combination in stable, chronic effort angina. Drugs Exp Clin Res. 1988;14:699-705.
89. Hetzel M, Wieshammer S, Barnikel U, et al. Effects of antianginal therapy with atenolol and slow-release nifedipine on respiratory gas exchange and on the ventilatory requirements for aerobic exercise. Z Kardiol. 1994;83(suppl 3):83-87.
90. Wieshammer S, Hetzel M, Barnikel U, et al. Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina. Klin Wochenschr. 1991; 69:645-651.
91. de Vries RJ, Dunselman PH, van Veldhuisen DJ, et al. Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients >65 years of age with angina pectoris. Am J Cardiol. 1994;74:1201-1206.
92. Akhras F, Chambers J, Jefferies S, Jackson G. A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina. Int J Cardiol. 1989;24:191-196.
93. Ankier SI, Fay L, Warrington SJ, Woodings DF. A multicentre open comparison of isosorbide-5-mononitrate and nifedipine given prophylactically to general practice patients with chronic stable angina pectoris. J Int Med Res. 1989;17:172-178.
94. Liang CS, Coplin B, Wellington K. Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina. Am J Cardiol. 1985; 55:9E-14E.
95. Connelly CM, Waksmonski C, Gagnon MM, Lipsitz LA. Effects of isosorbide dinitrate and nicardipine hydrochloride on postprandial blood pressure in elderly patients with stable angina pectoris or healed myocardial infarction. Am J Cardiol. 1995;75:291-293.
96. Eldridge JE, Burdick DC, Jones RH, Hossack KF. Comparison of nitroglycerin patches and nifedipine. J Cardiovasc Pharmacol. 1987;10:315-319.
97. Emanuelsson H, Ake H, Kristi M, Anna R. Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris. Eur J Clin Pharmacol. 1989;36:561-566.
98. von Amim T, Erath A, Reuschel-Janetschek E. Isosorbide-5-mononitrate and nifedipine can reduce ischaemic ST-segment changes during Holter monitoring in patients with spontaneous angina pectoris. Eur Heart J. 1988;9(suppl A):113-118.
99. Steffensen R, Melchior T, Bech J, et al. Effects of amlodipine and isosorbide dinitrate on exercise-induced and ambulatory ischemia in patients with chronic stable angina pectoris. Cardiovasc Drugs Ther. 1997;11:629-635.
100. Schneider W, Maul FD, Bussmann WD, et al. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment. Eur Heart J. 1988;9:149-158.
101. Friedensohn A, Meshulam R, Schlesinger Z. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes. Cardiology. 1991;79(suppl 2):31-40.
102. Carboni GP, Saltarocchi ML, Risa AL, Scardovi AB, Zanchi E, Prati PL. Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris. J Cardiovasc Pharmacol. 1992;20(suppl 7):S64-S70.
103. van de Ven LL, Vermeulen A, Tans JG, et al. Which drug to choose for stable angina pectoris. Int J Cardiol. 1995;47:217-223.
104. Waysbort J, Meshulam N, Brunner D. Isosorbide-5-mononitrate and atenolol in the treatment of stable exertional angina. Cardiology. 1991;79(suppl 2):19-26.
105. Krepp HP. Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris. Cardiology. 1991;79(suppl 2):14-18.
106. Aubert A, Nyberg G, Slaastad R, Tjeldflaat L. Prophylactic treatment of angina pectoris. BMJ. 1970;1: 203-206.
107. Binak K, Sirmaci N, Tavsanoglu 5, Harmanci N. Beta-adrenergic-blocker LB46 and isosorbide dinitrate synergism in angina pectoris. New Istanbul Contrib Clin Sci. 1974;11:8-23.
108. Goldbarg AN, Moran JF, Butterfield TK, et al. Therapy of angina pectoris with propranolol and long-acting nitrates. Circulation. 1969;40:847-853.
109. Alderman MH, Cohen H, Roque R, Madhavan S. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet. 1997;349:594-598.
110. Pandolfo L, Pajes G, Zardi D, Giorgi G. Anti ischaemic efficacy of amlodipine vs nifedipine in the treatment of patients with stable exertional angina. Clin Drug Invest 1997;13:113-118.
111. Licciardello G, Privitera A, Calvi V, et al. Amlodipine vs nifedipine. Clin Drug Invest 1997;13:119-125.
112. Zanolla L, Franceschini L, Rossi L, et al. Nifedipine GITS versus diltiazem in chronic stable angina. Br J Clin Pract Suppl. 1997;88:27-35.
113. Schulte KL. 24 h anti-anginal and anti-ischaemic effects with once daily felodipine. Eur Heart J. 1995;16:171-176.
114. Siu SC, Jacoby RM, Phillips RT, Nesto RW. Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris. Am J Cardiol. 1993; 71:887-892.
115. Donaldson KM, Dawkins KD, Waller DG. A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia. Eur Heart J. 1993;14:534-539.
116. Wang TJ, Stafford RS. National patterns and predictors of beta-blocker use in patients with coronary artery disease. Arch Intern Med. 1998;158:1901-1906.
117. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867-872.
118. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet. 1997;350:326-329.